Burton G. Malkiel, Director at Theravance Biopharma, Inc. (TBPH), bought 1,000 shares at $22.54 ($23K) on 2018-05-21, disclosed to the SEC on 2018-05-23.
Open-market purchase of $23k TBPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |